A federal appellate court has rejected Bidi Vapor’s request to stay the latest denial by the US Food and Drug Administration (FDA) of its premarket tobacco product application (PMTA).
The decision on 15th February from the US Court of Appeals for the Eleventh Circuit comes about a month after the FDA issued a marketing denial order (MDO) to Bidi that means the company can no longer sell its products in the US.
This article was written by one of ECigIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual vaping markets. For a full list, please see our Who We Are page.
Our Key Benefits
The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.
ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.
Stay informed of any legal and market change in the sector that impacts your organisation
Maximise resources by getting market and legal data analysis daily in one place
Make smart decisions by understanding how the regulatory and market landscape evolves
Anticipate risks in your decisions by monitoring regulatory changes that impact your organization
Thanks for getting in touch with us
Please leave your enquiry and we will get back to you within 24 hours
LATEST ALERTS
